Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.050
-0.050 (-2.38%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,119,849
Market Cap
5.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 2 | 20.00% |
| Dec 31, 2024 | 10 | -3 | -23.08% |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | 0 | - |
| Dec 31, 2021 | 15 | 1 | 7.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| HCW Biologics | 35 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| Purple Biotech | 10 |
| Dermata Therapeutics | 9 |
| Enveric Biosciences | 6 |
| Can-Fite BioPharma | 5 |
PCSA News
- 3 days ago - Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - Processa Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Processa buys Vidya Therapeutics, raises $200 million for drug trials - Reuters
- 5 weeks ago - Processa Pharmaceuticals Transcript: M&A announcement - Transcripts
- 5 weeks ago - Processa Pharmaceuticals Press release: M&A announcement - Filings
- 5 weeks ago - Processa Pharmaceuticals Slides: M&A announcement - Filings
- 5 weeks ago - Processa Pharmaceuticals acquires Vidya Therapeutics in stock-for-stock deal - TheFly
- 5 weeks ago - PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. - GlobeNewsWire